Article info
PDFResponse
Whole genome sequencing in children: ethics, choice and deliberation
- Correspondence to Dr Ainsley J Newson, Centre for Values, Ethics and the Law in Medicine (VELiM), Sydney School of Public Health, Level 1, Medical Foundation Building, 92-94 Parramatta Road, University of Sydney, NSW 2006, Australia; ainsley.newson{at}sydney.edu.au
Citation
Whole genome sequencing in children: ethics, choice and deliberation
Publication history
- Received December 22, 2016
- Accepted January 6, 2017
- First published January 27, 2017.
Online issue publication
July 26, 2017
Article Versions
- Previous version (26 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Genomic intensive care: should we perform genome testing in critically ill newborns?
- Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
- Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life
- Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access
- Cancer patients’ views and understanding of genome sequencing: a qualitative study
- Genomics for paediatricians: promises and pitfalls
- Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol
- The 100 000 Genomes Project: bringing whole genome sequencing to the NHS
- Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol
- Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases